Abstracts

964 – Evaluating the Accuracy of Standard F TB-Feron FIA for TB Infection Diagnosis in Vietnam

Background In Vietnam, national guidelines require a Tuberculosis (TB) infection test before TB preventive therapy can be administered. However, Interferon Gamma Release Assays (IGRAs) require advanced laboratories for processing, resulting in limited access. The Standard F TB-Feron fluorescent immunoassay (TB-Feron) is a simplified IGRA which requires less manual handling and no specialized laboratory staff. Methods This cross-sectional…

970 – Weekly Rifapentine and Isoniazid (3HP) vs Isoniazid Preventive Therapy (6H) Among People With HIV

Background People with HIV (PHIV) have a 30% lifetime risk of developing tuberculosis (TB) disease, which TB preventive therapy (TPT) reduces by 60%. Six-month daily isoniazid (6H) regimens are challenged by non-adherence and suboptimal completion. Shorter regimens such as 3-month weekly rifapentine and isoniazid (3HP) were introduced in Kenya in October 2022. There is a…

962 – Genome-Wide Meta-Analysis Identifies Genetic Associations With Resistance to Mtb Infection

Background Tuberculosis (TB) is the leading infectious cause of death worldwide, including among people living with HIV. The WHO End TB goal of reducing TB incidence to <10 cases per 100,000 will not be achieved without a greater understanding of host mechanisms that mediate susceptibility to Mycobacterium tuberculosis (Mtb). A genetic basis for “resistance” to Mtb…

983 – Burden of Opportunistic Infections and Causes of Death in Hospitalized Patients With AHD in Vietnam

Background Most global AIDS deaths occur in hospitalized patients with advanced HIV disease (AHD), yet data on the major killers among this population are lacking. We investigated the burden of opportunistic infections (OIs) and causes of death in hospitalized patients with AHD in Vietnam to inform policy and intervention strategies. Methods In this multi-center prospective…

930 – Persistent Immune Dysregulation and Metabolic Alterations Following SARS-CoV-2 Infection

Background SARS-CoV-2 infection can lead to medical comorbidities (eg, autoimmunity, vascular complications) as well as Long COVID (LC), a multisystem disease encompassing a wide range of symptoms. The biological drivers of these conditions are incompletely understood. Methods We performed an in-depth immunometabolic screen with multidimensional flow cytometry and plasma measurements of inflammatory biomarkers and metabolites.…

927 – Hormonal Dysregulation in Long COVID: Exploring the Salivary Cortisol Profile

Background While reduced morning serum cortisol (SC) is common in long COVID (LC) patients, measuring salivary cortisol throughout the day better reflects dynamic secretion and may offer greater sensitivity than SC. This study investigates this relationship, alongside hormonal dysregulation and LC predictors. Methods This prospective, single-center, case-control study at a LC-clinic in Rome included 96…

980 – Factors Associated With Virologic Suppression in People Living With HIV and Tuberculosis in Brazil

Background Data from national programs are key to evaluate antiretroviral therapy (ART) virologic effectiveness in real-life settings, especially in people with HIV (PWH) receiving treatment for tuberculosis (TB) . The objective of the present study was to evaluate factors associated with virologic suppression within the Brazilian national HIV/TB program. Methods A retrospective cohort study was conducted from…

972 – Effect of Tuberculosis Preventive Therapy on Mtb-Specific T-Cell Profile in the A5279/BRIEF TB Trial

Background People with HIV (PWH) have impaired Mycobacterium tuberculosis (Mtb)-specific T cell responses, making induction of effective immunity challenging. Whether TB preventive therapy (TPT) modifies Mtb-specific T cell profile in PWH is unknown. We interrogated Mtb antigen-specific T cell responses in PWH with latent TB infection (LTBI) pre- and post-TPT within the ACTG A5279 clinical…